讲故事对减少儿科患者程序性困扰的影响
Bhasara Kalpana Ramji1, Mahalakshmi B1, Siva Subramanian N2
1Department of Pediatric Nursing, Nootan College of Nursing, Sankalchand Patel University, Visnagar, Gujarat, India.
Bioinformation
|February 2, 2026
概括
讲故事可以显著减少儿童在医疗过程中的生理痛苦. 这种低成本的干预措施可以改善生命体征和氧气和,为标准护理提供安全的补充.
科学领域:
- 儿科护理 儿科护理
- 儿童心理学 儿童心理学
- 医疗干预 医学干预
背景情况:
- 侵入性医疗程序可能会对儿童造成严重的痛苦.
- 寻求非药物干预来管理程序性焦虑和疼痛.
研究的目的:
- 评估讲故事对儿童进行侵入性医疗手术的生理反应的影响.
- 为了确定讲故事是否可以减少程序上的痛苦,并改善患者的结果.
主要方法:
- 采用了一组测试前测试后测试设计.
- 3-12岁的41名儿童参加了这次活动.
- 在15-20分钟的讲故事会之前和之后测量了生理参数.
主要成果:
- 观察到呼吸速率,脉速率,静脉血压,腹静脉血压和体温的显著降低.
- 氧和度 (SpO2) 显示显著改善.
- 讲故事在痛苦的多个生理指标上表现出可衡量的积极影响.
结论:
- 讲故事是一种有效的,低成本的,在文化上适应的干预措施,可以减少儿童的程序性痛苦.
- 将讲故事纳入儿科护理护理可以作为药理方法的安全补充.
- 这种非药理学方法有可能在儿科卫生保健机构中常规使用.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
262
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
262
Pharmacokinetics in Pediatric Patients: Drug Distribution
304
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism
226
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
226
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
296
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
296
Reducing Line Loss
390
In a three-phase circuit, line loss is an indicator of energy dissipated as heat due to the resistance of transmission lines. To address this, incorporating transformers into the system—a step-up transformer at the source and a step-down transformer at the load—is a strategic solution. Two three-phase transformers are introduced to improve this.
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
390
Methods of reducing fever
1.4K
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
1.4K


